# Verikai

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/verikai

- Industry: Financial Services
- Headquarters: San Francisco, US
- Website: www.verikai.com
- Total disclosed funding: $6.9M
- Latest round: Series A (Mar 31, 2020)
- Investors on record: 3

## About

Verikai Inc. specializes in advanced risk assessment solutions that utilize data analysis to enhance healthcare insights for insurance companies, improving their decision-making processes related to health risks.Founded in 2018, Verikai Inc. is based in San Francisco, US, and focuses on transforming healthcare data into actionable insights. The company recently raised USD 6.90 mn in a Series A funding round led by ManchesterStory Group on January 18, 2022, which represents the total amount raised to date. Brett Coffin is the founder, who has prior experience in launching companies in the tech sector.Verikai offers advanced risk assessment solutions designed to transform data into actionable healthcare insights, focusing on the integration of medical, pharmaceutical, and lifestyle data. Their core product offerings, including Capture®Lifestyle, Capture®Health, and Capture®360, utilize advanced analytics and machine learning to predict health risks, ultimately aiding insurance underwriters in making informed decisions. These solutions cater to a diverse client base, including insurance companies that handle fully insured, stop-loss, and level-funded health plans. Verikai's products are primarily utilized across the United States, where they are implemented to enhance underwriting processes and optimize risk assessments by enabling clients to navigate potential health risks with precision. The company's innovative approach incorporates a holistic view of health data, which allows for comprehensive analysis and insights tailored to the healthcare industry.Verikai's revenue model is built upon providing subscription-based access to its suite of risk assessment tools and analytics services. Clients, primarily in the insurance sector, engage in partnerships to leverage Verikai’s proprietary data and insights, enhancing their underwriting capabilities. The transaction structure typically involves contractual agreements for access to the Capture® suite, wherein clients pay fees for ongoing support, updates, and system integration services. This model facilitates a steady revenue stream as clients rely on Verikai's innovative solutions for critical decision-making processes. The firm’s flagship products are centered around their Capture® brand, which underscores their commitment to delivering precise and actionable insights in healthcare risk assessment.As of January 2022, Verikai is preparing for continued growth following its acquisition agreement with American Financial Group, Inc., though specific financial terms were not disclosed. The company aims to enhance its product offerings, focusing on new features for its Capture® suite set to launch within the next year. Additionally, Verikai is exploring expansion opportunities into new geographic markets, with plans to reach additional regions in North America by 2024. The recent funding will be utilized to support these initiatives, specifically in product development and expanding their market presence.

## Funding rounds

- Series A, Mar 31, 2020, $6.9M — Plug and Play, ManchesterStory, ValueStream Ventures

## Investors

- Plug and Play (https://capitalatlas.ai/funds/plug-and-play) — Series A
- ManchesterStory (https://capitalatlas.ai/funds/manchesterstory) — Series A
- ValueStream Ventures (https://capitalatlas.ai/funds/valuestream-ventures) — Series A